The life sciences industry experienced a turbulent but ultimately productive year in 2025. The public markets saw a volatile downward swing in the first half of 2025, but quickly regained footing and rebounded in the second half of the year. Venture investment remained tempered throughout the year, signaling continued discipline among investors. M&A largely tracked the upward trend of the public markets, with an initially muted start followed by a strong uptick in deal volume to close out 2025. Licensing deal volume rose strongly in 2025, with continuing prominence in Chinese in-licensing. This article explores these and other key trends of the life sciences sector in 2025 and offers insights into how they may shape what’s to come in 2026.
Read the full article: From Volatility to Vitality: How 2025 Reset the Life Sciences Market and What’s Next for 2026 //
Source: https://www.lexology.com/library/detail.aspx?g=2472605a-a530-4fea-bdb4-b68612880507
